Global Embolotherapy Market To Reach USD 7.88 Billion by 2032 With A CAGR Of 7.92%

The embolotherapy market is expected to surpass USD 7.88 Billion by 2032 from USD 3.97 Billion in 2023 with a CAGR of 7.92%, as per Zion Market Research. Rising funds, investments, and grants by public-private agencies for research; rising occurrences of liver cancer, peripheral vascular diseases, uterine fibroids, and strokes paired with increasing preference for minimally invasive procedures; and technical enhancements in the market will power the growth of the market.

The key players in the global market comprise Merit Medical Systems, Boston Scientific Corporation, Medtronic plc, Meril Life Sciences Pvt. Ltd., Terumo Corporation, Stryker Corporation, Johnson & Johnson, Penumbra, Inc., BTG plc, Abbott Laboratories, Cook Medical, BALT Extrusion, Acandis GmbH, Kaneka Corporation, and Sirtex Medical Limited, amongst others.

Microspheres Segment Added Up For The Biggest Share Of The Global Embolotherapy Market By Product

On the basis of product, the global market is divided broadly into support devices and embolic agents. The embolic agents section is additionally divided into embolic plug systems, embolic coils, microspheres, liquid embolic agents, and detachable balloons. The support devices segment comprises guidewires and microcatheters. The microspheres section below embolic agents held the biggest global market share in 2023. The growth of this section is primarily boosted by the increase in the occurrence of hepatocellular carcinoma paired with complimentary reimbursement criteria in developed nations. In addition to this, new product approvals and launches are further supporting the segment growth.

Hospitals And Clinics End User Segment To Get The Maximum Income In The Embolotherapy Market

On the basis of end user, the global market is divided into ambulatory surgery centers (ASCs), hospitals and clinics, and others. Hospitals and clinics are the major end users of the market. This section includes the embolotherapy devices employed in small clinics, big hospitals, and ICUs. The rising purchasing power of primary healthcare suppliers all over developed nations, increasing acceptance of minimally invasive surgical operations, and the greater accessibility of reimbursements for target processes in major European nations and the US are the primary factors that are projected to boost the requirement for embolization machine in clinics and hospitals.

Asia Pacific Market Projected To Develop At The Maximum CAGR In The Years To Come

The embolotherapy market is divided into 5 main areas such as Europe, North America, Latin America, Asia Pacific, and the Middle East & Africa. Enhancing healthcare infrastructure in the area, the huge population of patient for target diseases, and extending existence of major players in the market in the region to grab increasing opportunities provided by these nations are the major factors supporting the growth of the market.

Browse the full “Embolotherapy Market by Disease (Aneurysm, Oncology, Peripheral Vascular), Product (Guidewires, Embolic Agents (Detachable Coils, Microspheres, Pushable Coils)), Procedure, End User (Clinics, Hospitals, Academia, ASC) - Global Industry Perspective, Comprehensive Analysis, and Forecast, 2024–2032.” Report at https://www.zionmarketresearch.com/report/embolotherapy-market

The global embolotherapy market is segmented as follows:

By Product

• Embolic agents
• Microspheres
• Embolic coils
  • Detachable Coils
  • Pushable Coils
• Liquid Embolic Agents
• Embolic Plug Systems
• Detachable Balloons
• Support Devices
• Microcatheters
• Guidewires

By Disease Indication

• Cancer
• Liver Cancer
• Kidney Cancer
• Other Cancers
• Peripheral Vascular Diseases
• Neurological Diseases
• Cerebral Aneurysm
• Cerebral Arteriovenous Malformations and Fistulas
• Gastrointestinal Disorders
• Urological and Nephrological Disorders

By Procedure

• Transcatheter Arterial Embolization
• Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy
• Transarterial Chemoembolization

By End User

• Hospitals and Clinics
• Ambulatory Surgical Centers
• Other End Users

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa

About Us:

Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Contact Us:

Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com